Amidate is a small molecule that works as a GABA-a Receptor; Anion Channel Positive Modulator.[2] It is being used across 11 indications, with its most advanced program in Approved.[1]
Amidate is one of 293 small molecule programs targeting Respiratory Failure. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
687 competitors in Heart Failure
Amidate
Bayer Aspirin
Brethine
Medrol
LCZ696
Zemplar
Savaysa
Coumadin
Xylocaine
Tamiflu
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Sep 7, 1982
AMIDATE
NDA NDA018227
Sources